The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

WASHINGTON (AP) — The Trump administration has frozen, stalled or otherwise disrupted some $430 billion in federal funds — ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

(Reuters) -Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary Robert F. Kennedy Jr. raised concerns about the company's COVID-19 ...

NEW YORK — President Donald Trump has launched tariff wars with nearly all of America’s trading partners. And there’s no end in sight. A number of sweeping new taxes on goods from other ...

Just last week, the US Food and Drug Administration delayed a decision on full approval of Novavax’s Covid-19 vaccine even though it was on track to be cleared, leaving many public health ...

Novavax has faced significant regulatory setbacks in recent months that make its prospects uncertain. President Trump's trade policies are sending many stocks that were performing well in the ...

Full Food and Drug Administration approval would allow the vaccine to be used more widely and could offer more reassurance to people looking for options besides the existing mRNA vaccines.

The delay dovetails with moves by Republican lawmakers in at least 7 states to ban or limit mRNA vaccines. HealthDay News — The US Food and Drug Administration (FDA) has delayed the full ...